BiotechTube
Home/Cambrian Bio/James Peyer
JP

James Peyer

CEO and Founder

Cambrian Bio

Therapeutic Areas

AgingMetabolic DiseasesAge-related Chronic Diseases

Cambrian Bio Pipeline

DrugIndicationPhase
TORnado Platform (Selective mTORC1 Inhibitor)Improving Intrinsic Capacity in Older Adults / Age-related Metabolic DeclinePhase 1
Amplifier Therapeutics PlatformAge-related Metabolic Decline / Cardiometabolic DiseasePre-clinical

Leadership Team at Cambrian Bio

JH
Juliette Han
CFO/COO
View full Cambrian Bio profile